Home/Filings/4/0001640334-25-001136
4//SEC Filing

Gorgas Gregory D. 4

Accession 0001640334-25-001136

CIK 0001621221other

Filed

Jul 6, 8:00 PM ET

Accepted

Jul 7, 4:40 PM ET

Size

8.4 KB

Accession

0001640334-25-001136

Insider Transaction Report

Form 4
Period: 2025-07-02
Gorgas Gregory D.
DirectorPresident, CEO, CFO, Treasurer
Transactions
  • Award

    Stock Option (right to buy)

    2025-07-02+20,00020,000 total
    Exercise: $11.03Exp: 2035-07-02Common Stock (20,000 underlying)
  • Award

    Stock Option (right to buy)

    2025-07-02+20,39320,393 total
    Exercise: $11.03Exp: 2035-07-02Common Stock (20,393 underlying)
Footnotes (2)
  • [F1](1) Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, one forty-eighth (1/48th) of the shares subject to the option shall vest each month following the Vesting Commencement Date on the same day of the month as the Vesting Commencement Date, such that the option shall be fully vested on the four (4) year anniversary of the Vesting Commencement Date. Vesting Commencement Date shall mean January 1, 2025.
  • [F2](2) Subject to the Reporting Person continuing to be a Service Provider (as such term is defined in the Issuer's 2018 Equity Incentive Plan) through each such applicable vesting date, fifty percent (50%) of the shares subject to the option shall vest January 1, 2026 and the remaining fifty percent (50%) of the shares subject to the option shall vest January 1, 2027.

Issuer

ARTELO BIOSCIENCES, INC.

CIK 0001621221

Entity typeother

Related Parties

1
  • filerCIK 0001526251

Filing Metadata

Form type
4
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:40 PM ET
Size
8.4 KB